BRIEF-Bioaffinity Technologies Announces Acceptance Of Patent Application For Early-Stage Lung Cancer Diagnostic

Reuters
22 Jan
BRIEF-Bioaffinity Technologies Announces Acceptance Of Patent Application For Early-Stage Lung Cancer Diagnostic

Jan 22 (Reuters) - bioAffinity Technologies Inc BIAF.O:

  • BIOAFFINITY TECHNOLOGIES ANNOUNCES ACCEPTANCE OF PATENT APPLICATION FOR EARLY-STAGE LUNG CANCER DIAGNOSTIC

  • BIOAFFINITY TECHNOLOGIES INC - AUSTRALIAN PATENT FOR CYPATH LUNG TEST TO EXPIRE IN 2042

Source text: ID:nBw6fQqrCa

Further company coverage: BIAF.O

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10